Home Theravance Biopharma

Theravance Biopharma

acquired
IPO Delisting
Innovative Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Theravance Biopharma, Inc. ("Theravance Biopharma") is a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective drugs. Our purpose is to create transformative medicines to improve the lives of patients suffering from serious diseases. Our research focuses on the fields of inflammation and immunology. To achieve our goals, we apply insights and innovation at every stage of our operations and leverage both our internal capabilities and those of our global partners. We apply our organ-selective expertise to biologically significant targets to discover and develop drugs aimed at treating underserved localized diseases and limiting systemic exposure to maximize patient benefits and minimize risks.
Theravance Biopharma, Inc.
SanFrancisco,California,United States of America
101~500 people
January 01, 1996
investor.relations@theravance.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Disease Treatment Immune System Diseases Respiratory Diseases
Application Scenarios
Innovative Drugs